ORIGINAL PAPER
The impact of smoking on finger dexterity and dual-task activities in elderly adults: a cross-sectional study
 
More details
Hide details
1
Department of Physiotherapy, Jamia Hamdard, New Delhi, India
 
2
Centre for Physiotherapy and Rehabilitation Sciences, Jamia Millia Islamia (Central University), New Delhi, India
 
These authors had equal contribution to this work
 
 
Submission date: 2023-11-15
 
 
Acceptance date: 2024-05-09
 
 
Publication date: 2025-06-18
 
 
Corresponding author
Hammad Ahmed Siddiqui   

Department of Physiotherapy, Jamia Hamdard, Hamdard Nagar, New Delhi-110062, India
 
 
Physiother Quart. 2025;33(2):34-38
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Extensive research has focused on the cardiovascular, pulmonary, and cancer-related health consequences of smoking. However, there is a lack of specific investigations into the consequences of prolonged smoking on human neurocognition and neurobiology, particularly related to finger dexterity and dual-tasking abilities in elderly individuals. Understanding the impact of smoking on dual-tasking conditions and finger dexterity can provide valuable insights into potential cognitive decline and impairment in daily activities among elderly smokers.

Methods:
This study recruited 40 subjects based on inclusion and exclusion criteria by convenience sampling of an old age home in Delhi. Participants were divided into elderly smokers (group 1) and non-smokers (group 2) by self-reported smoking status and the results of a Fagerstrom Test for Nicotine Dependence (FTND) questionnaire. Both groups performed dual-task finger dexterity using the nine-hole peg board (9HPT) and were assessed for task speed and activities of daily living (ADL). ADL was assessed using the Katz Index of Independence in ADL (KATZ). Data were analysed to detect differences between the groups.

Results:
The study findings indicated a statistically significant difference between group 1 and group 2 in the 9HPT (p < 0.05). There were statistically significant differences between group 1 and group 2 in dual-task cognitive 9HPT (C9HPT) and motor 9HPT (M9HPT) tests (p < 0.05). However, analysis using the KATZ found between-group differences.

Conclusions:
Smoking had a negative impact on dual-task finger dexterity, potentially due to its effects on neurocognition and neurobiology.
REFERENCES (41)
1.
Zapparoli L, Mariano M, Paulesu E. How the motor system copes with aging: a quantitative meta-analysis of the effect of aging on motor function control. Commun Biol. 2022;5(1):79; doi: 10.1038/s42003-022-03027-2.
 
2.
Mecocci P, Von Strauss E, Cherubini A, Ercolani S, Mariani E, Senin U, Winblad B, Fratiglioni L. Cognitive impairment is the major risk factor for development of geriatric syndromes during hospitalization: results from the GIFA study. Dement Geriatr Cogn Dis. 2005;20(4):262–9; doi: 10.1159/000087440.
 
3.
Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR. Mild cognitive impairment: ten years later. Arch Neurol. 2009;66(12):1447–55; doi: 10.1001/archneurol.2009.266.
 
4.
Schmahmann JD. Dysmetria of thought: clinical consequences of cerebellar dysfunction on cognition and affect. Trends Cogn Sci. 1998;2(9):362–71; doi: 10.1016/s1364-6613(98)01218-2.
 
5.
Brayne C, Gill C, Huppert FA, Barkley C, Gehlhaar E, Girling DM, O’Connor DW, Paykel ES. Vascular risks and incident dementia: results from a cohort study of the very old. Dement Geriatr Cogn Disord. 1998;9(3):175–80; doi: 10.1159/000017043.
 
6.
Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C, Sinning C, Tzikas S, Keller T, Genth-Zotz S, Lackner KJ, Münzel TF, Blankenberg S. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the Athero Gene study. Eur Heart J. 2008;29(5):649–57; doi: 10.1093/eurheartj/ehn009.
 
7.
Sivapuram MS, Nagarathna R, Anand A, Patil S, Singh A, Nagendra HR. Prevalence of alcohol and tobacco use in India and implications for COVID-19-Niyantrita Madhumeha Bharata study projections. J Med Life. 2020;13(4):499–509; doi: 10.25122/jml-2020-0079.
 
8.
Shimkhada R, Peabody JW. Tobacco control in India. Bull World Health Organ. 2003;81(1):48–52.
 
9.
Lushniak BD, Samet JM, Pechacek TF, Norman LA, Taylor PA. The health consequences of smoking – 50 years of progress: a report of the Surgeon General. 2014. Available from: https://stacks.cdc.gov/view/cd... (assessed 20-06-2023).
 
10.
Krist AH, Davidson KW, Mangione CM, Barry MJ, Caba­na M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Landefeld CS, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng C-W, Wong JB. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(10):962–70; doi: 10.1001/jama.2021.1117.
 
11.
Nonnemaker J, Rostron B, Hall P, MacMonegle A, Apelberg B. Mortality and economic costs from regular cigar use in the United States, 2010. Am J Public Health. 2014;104(9):e86–91; doi: 10.2105/AJPH.2014.301991.
 
12.
Jamal A, Homa DM, O’Connor E, Babb SD, Caraballo RS, Singh T, Hu SS, King BA. Current cigarette smoking among adults – United States, 2005–2014. Morb Mortal Weekly Rep. 2015;64(44):1233–40; doi: 10.15585/mmwr.mm6444a2.
 
13.
Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341–50; doi: 10.1056/NEJMsa1211128.
 
14.
Scharffetter-Kochanek K, Wlaschek M, Brenneisen P, Schauen M, Blaudschun R, Wenk J. UV-induced reactive oxygen species in photocarcinogenesis and photoaging. Biol Chem. 1997;378(11):1247–58.
 
15.
Edemekong PF, Bomgaars DL, Sukumaran S, Schoo C. Activities of Daily Living. 2023 Jun 26. In: StatPearls. Treasure Island: StatPearls Publishing; 2025.
 
16.
Durazzo TC, Meyerhoff DJ, Nixon SJ. Chronic cigarette smoking: implications for neurocognition and brain neurobiology. Int J Environ Res Public Health. 2010;7(10):3760–91; doi: 10.3390/ijerph7103760.
 
17.
Durazzo TC, Mattsson N, Weiner MW; Alzheimer’s Disease Neuroimaging Initiative. Smoking and increased Alzheimer’s disease risk: a review of potential mechanisms. Alzheimers Dement. 2014;10(3S):122–45; doi: 10.1016/j.jalz.2014.04.009.
 
18.
Rusanen M, Kivipelto M, Quesenberry CP, Zhou J, Whitmer RA. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Int Med. 2011;171(4):333–9; doi: 10.1001/archinternmed.2010.393.
 
19.
Cataldo JK, Prochaska JJ, Glantz SA. Cigarette smoking is a risk factor for Alzheimer’s Disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis. 2010;19(2):465–80; doi: 10.3233/JAD-2010-1240.
 
20.
Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing. 2008;37(5):505–12; doi: 10.1093/ageing/afn095.
 
21.
Anstey KJ, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166(4):367–78; doi: 10.1093/aje/kwm116.
 
22.
Dinkla S, van Eijk LT, Fuchs B, Schiller J, Joosten I, Brock R, Pickkers P, Bosman GJ. Inflammation-associated changes in lipid composition and the organization of the erythrocyte membrane. BBA Clin. 2016;5:186–92; doi: 10.1016/j.bbacli.2016.03.007.
 
23.
Mattson MP, Arumugam TV. Hallmarks of brain aging: adaptive and pathological modification by metabolic states. Cell Metab. 2018;27(6):1176–99; doi: 10.1016/j.cmet.2018.05.011.
 
24.
Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neurorep. 1993;4(8):1027–30; doi: 10.1097/00001756-199308000-00008.
 
25.
Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, Hensley K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis. 2008;15(3):473–93; doi: 10.3233/jad-2008-15314.
 
26.
Götz J, Ittner LM. Animal models of Alzheimer’s disease and frontotemporal dementia. Nat Rev Neurosci. 2008;9(7):532–44; doi: 10.1038/nrn2420.
 
27.
Stern M, McNew JA. A transition to degeneration triggered by oxidative stress in degenerative disorders. Mol Psychiatry. 2021;26(3):736–46; doi: 10.1038/s41380-020-00943-9.
 
28.
Vignini A, Sartini D, Morganti S, Nanetti L, Luzzi S, Provinciali L, Mazzanti L, Emanuelli M. Platelet amyloid precursor protein isoform expression in Alzheimer’s disease: evidence for peripheral marker. Int J Immunopathol Pharmacol. 2011;24(2):529–34; doi: 10.1177/039463201102400229.
 
29.
Freiberger E, Sieber C, Pfeifer K. Physical activity, exercise, and sarcopenia-future challenges. Wien Med Wo­chenschr. 2011;161(17–18):416–25; doi: 10.1007/s10354-011-0001-z.
 
30.
Li KZ, Lindenberger U. Relations between aging sensory/sensorimotor and cognitive functions. Neurosci Bio­behav Rev. 2002;26(7):777–83; doi: 10.1016/s0149-7634(02)00073-8.
 
31.
Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord. 2008;23(3):329–42; doi: 10.1002/mds.21720.
 
32.
Hausdorff JM, Schweiger A, Herman T, Yogev-Seligmann G, Giladi N. Dual-task decrements in gait: contributing factors among healthy older adults. J Gerontol A Biol Sci Med Sci. 2008;63(12):1335–43; doi: 10.1093/gerona/63.12.1335.
 
33.
Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF. Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom test for nicotine dependence. Addict Behav. 1994;19(1):33–9; doi: 10.1016/0306-4603(94)90049-3.
 
34.
Mathiowetz V, Weber K, Kashman N, Volland G. Adult norms for the Nine Hole Peg Test of finger dexterity. Occup Ther J Res. 1985;5(1):24–38.
 
35.
Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc. 1983;31(12):721–7; doi: 10.1111/j.1532-5415.1983.tb03391.x.
 
36.
Waisman Campos M, Serebrisky D, Mauricio Castaldelli-Maia J. Smoking and cognition. Curr Drug Abuse Rev. 2016;9(2):76–9; doi: 10.2174/1874473709666160803101633.
 
37.
Stramecki F, Kotowicz KD, Piotrowski P, Frydecka D, Rymaszewska J, Beszłej JA, Samochowiec J, Jabłoń­ski M, Wroński M, Moustafa AA, Misiak B. Assessment of the association between cigarette smoking and cognitive performance in patients with schizophrenia-spectrum disorders: a case-control study. Front Psychiatry. 2018;9:642; doi: 10.3389/fpsyt.2018.00642.
 
38.
Suzumura S, Osawa A, Nagahama T, Kondo I, Sano Y, Kandori A. Assessment of finger motor skills in individuals with mild cognitive impairment and patients with Alzheimer’s disease: relationship between finger-to-thumb tapping and cognitive function. Jap J Compr Rehabil Sci. 2016;7:19–28; doi: 10.11336/jjcrs.7.19 .
 
39.
Amini R, Sahli M, Ganai S. Cigarette smoking and cognitive function among older adults living in the community. Aging Neuropsychol Cogn. 2021;28(4):616–31; doi: 10.1080/13825585.2020.1806199.
 
40.
Mazzone P, Tierney W, Hossain M, Puvenna V, Janigro D, Cucullo L. Pathophysiological impact of cigarette smoke exposure on the cerebrovascular system with a focus on the blood-brain barrier: expanding the awareness of smoking toxicity in an underappreciated area. Int J Environ Res Public Health. 2010;7(12):4111–26; doi: 10.3390/ijerph7124111.
 
41.
Dziubek W, Kowalska J. An evaluation of the usefulness of Comprehensive Geriatric Assessment in patients after a fracture within the proximal femoral epiphysis while staying at a nursing home – a pilot study. Physiother Q. 2023;31(2):85–91; doi: 10.5114/pq.2023.125752.
 
eISSN:2544-4395
Journals System - logo
Scroll to top